Clinical Trial

Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures

Study acronym: INSiGHT
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to collect data on the usability and integration of the VERAFEYE Imaging and Guidance System in adult patients indicated to undergo a standard of care catheter-based ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF (PAF) or persistent AF (perAF). Results from this study may be used to guide development and refinement the VERAFEYE Imaging and Guidance System capabilities.
Protocol Amendment History 4 changes
notable Primary completion pushed: 2026-09-15 -> 2026-10-15 2026-06-11
minor Completion pushed: 2026-09-15 -> 2026-10-15 2026-06-11
notable Primary completion pushed: 2026-08-15 -> 2026-09-15 2026-05-08
minor Completion pushed: 2026-08-15 -> 2026-09-15 2026-05-08
Trial Details
NCT Number NCT07271238
Lead Sponsor LUMA Vision Ltd.
Conditions Atrial Fibrillation, Atrial Flutter, Atrial Arrhythmia
Enrollment 50 participants
Start Date 2026-03-03
Primary Completion 2026-10-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-07